Skip to main content
. 2016 Feb 11;44(9):4189–4199. doi: 10.1093/nar/gkw087

Figure 3.

Figure 3.

Effect of the RAD52 inhibitors on survival (A) Capan-1 (BRCA2) and BxPC3 (BRCA2+) cells and (B) on UWB1.289 (BRCA1) and [UWB1.289 (+BRCA1)] (BRCA1+) cells. Capan-1 and UWB1.289 are denoted by red line; BxPC3 and UWB1.289 (+BRCA1) indicated by blue line. The experiments were repeated at least three times, error bars indicate SD.